As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

After AstraZeneca (AZN) presented data at the ObesityWeek conference, Deutsche Bank said the company’s oral small molecule GLP1 drug ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and ...

Researchers are weighing the effects of popular weight-loss medications like Ozempic on muscle mass. New work is "calling ...

Dr. Nora Volkow, Director of the National Institutes of Health’s National Institute on Drug Abuse (NIDA), discusses her ...

For those considering these medications, understanding semaglutide pros and cons ... However, a new study shows skeptical ...

Metabolic and vascular disorders are risk factors for AD, and it has been suggested that medications to treat metabolic and ...

So the FDA is warning patients about this, and says they should tell their doctor if they are taking Ozempic or any of these drugs before undergoing a surgery or other procedure.